日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Brand-specific influenza vaccine effectiveness in three Nordic countries during the 2024-2025 season: a target trial emulation study based on registry data

2024-2025 年流感季北欧三国特定品牌流感疫苗有效性:基于注册数据的目标试验模拟研究

Faksova, Kristyna; Thiesson, Emilia Myrup; Pihlström, Nicklas; Baum, Ulrike; Biering-Sørensen, Tor; Poukka, Eero; Leino, Tuija; Ljung, Rickard; Hviid, Anders

Feasibility of conducting brand-specific influenza vaccine effectiveness studies in three Nordic countries, Denmark, Finland, Sweden

在丹麦、芬兰和瑞典这三个北欧国家开展特定品牌流感疫苗有效性研究的可行性

Faksova, Kristyna; Thiesson, Emilia Myrup; Pihlström, Nicklas; Baum, Ulrike; Poukka, Eero; Leino, Tuija; Ljung, Rickard; Hviid, Anders

Efficacy and safety of respiratory syncytial virus vaccines

呼吸道合胞病毒疫苗的有效性和安全性

Saif-Ur-Rahman, K M; King, Catherine; Whelan, Seán Olann; Blair, Matthew; Donohue, Seán; Madden, Caoimhe; Kothari, Kavita; Sommer, Isolde; Harder, Thomas; Dauby, Nicolas; Moustsen-Helms, Ida Rask; Ruta, Simona; Frère, Julie; Schönfeld, Viktoria; Poukka, Eero; Lutsar, Irja; Olsson, Kate; Melidou, Angeliki; Adel Ali, Karam; Dwan, Kerry; Devane, Declan

Influenza Epidemiology in Finland During and After the COVID-19 Pandemic: Surveillance Data Analysis (2019-2024)

芬兰在 COVID-19 大流行期间及之后的流感流行病学:监测数据分析(2019-2024 年)

Baum, Ulrike; Ikonen, Niina; Luomala, Oskari; Poukka, Eero; Leino, Tuija; Nohynek, Hanna

Relative effectiveness of bivalent boosters against severe COVID-19 outcomes among people aged ≥ 65 years in Finland, September 2022 to August 2023

2022年9月至2023年8月,芬兰65岁及以上人群中二价加强针预防重症COVID-19的相对有效性

Poukka, Eero; Perälä, Jori; Nohynek, Hanna; Goebeler, Sirkka; Auranen, Kari; Leino, Tuija; Baum, Ulrike

Bias in control selection associated with the use of rapid tests in influenza vaccine effectiveness studies

流感疫苗有效性研究中使用快速检测方法可能导致对照组选择偏差

Poukka, Eero; Murphy, Caitriona; Mak, Loretta; Cheng, Samuel M S; Peiris, Malik; Tsang, Tim K; Sullivan, Sheena G; Cowling, Benjamin J

Comparative effectiveness of monovalent XBB.1.5 containing covid-19 mRNA vaccines in Denmark, Finland, and Sweden: target trial emulation based on registry data

丹麦、芬兰和瑞典单价含XBB.1.5的COVID-19 mRNA疫苗的比较有效性:基于注册数据的目标试验模拟

Andersson, Niklas Worm; Thiesson, Emilia Myrup; Pihlström, Nicklas; Perälä, Jori; Faksová, Kristýna; Gram, Mie Agermose; Poukka, Eero; Leino, Tuija; Ljung, Rickard; Hviid, Anders

Comparative effectiveness of heterologous third dose vaccine schedules against severe covid-19 during omicron predominance in Nordic countries: population based cohort analyses

在北欧国家奥密克戎毒株占主导地位期间,异源第三剂疫苗接种方案对重症新冠肺炎的比较有效性:基于人群的队列分析

Andersson, Niklas Worm; Thiesson, Emilia Myrup; Baum, Ulrike; Pihlström, Nicklas; Starrfelt, Jostein; Faksová, Kristýna; Poukka, Eero; Lund, Lars Christian; Hansen, Christian Holm; Aakjær, Mia; Kjær, Jesper; Cohet, Catherine; Goossens, Mathijs; Andersen, Morten; Hallas, Jesper; Meijerink, Hinta; Ljung, Rickard; Hviid, Anders

Comparative effectiveness of bivalent BA.4-5 and BA.1 mRNA booster vaccines among adults aged ≥50 years in Nordic countries: nationwide cohort study

北欧国家50岁及以上成年人中二价BA.4-5和BA.1 mRNA加强疫苗的比较有效性:全国性队列研究

Andersson, Niklas Worm; Thiesson, Emilia Myrup; Baum, Ulrike; Pihlström, Nicklas; Starrfelt, Jostein; Faksová, Kristýna; Poukka, Eero; Meijerink, Hinta; Ljung, Rickard; Hviid, Anders

Dawn of the hybrid immunity era in long-term care facilities

长期护理机构混合免疫时代的曙光

Poukka, Eero; Baum, Ulrike